nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—L-Phenylalanine—TH—polycystic ovary syndrome	0.0187	1	CrCbGaD
Felbamate—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0153	0.0772	CcSEcCtD
Felbamate—Hypothermia—Metformin—polycystic ovary syndrome	0.0153	0.0772	CcSEcCtD
Felbamate—CYP2C19—urine—polycystic ovary syndrome	0.0132	0.21	CbGeAlD
Felbamate—Rigors—Metformin—polycystic ovary syndrome	0.0105	0.053	CcSEcCtD
Felbamate—CYP2E1—urine—polycystic ovary syndrome	0.00972	0.154	CbGeAlD
Felbamate—CYP3A4—urine—polycystic ovary syndrome	0.00782	0.124	CbGeAlD
Felbamate—Renal impairment—Metformin—polycystic ovary syndrome	0.00654	0.033	CcSEcCtD
Felbamate—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00638	0.0322	CcSEcCtD
Felbamate—Migraine—Metformin—polycystic ovary syndrome	0.00613	0.0309	CcSEcCtD
Felbamate—GRIN2A—adrenal gland—polycystic ovary syndrome	0.00604	0.096	CbGeAlD
Felbamate—GRIN2B—endocrine gland—polycystic ovary syndrome	0.00599	0.0952	CbGeAlD
Felbamate—Dehydration—Metformin—polycystic ovary syndrome	0.00579	0.0292	CcSEcCtD
Felbamate—GRIN2A—vagina—polycystic ovary syndrome	0.0056	0.0889	CbGeAlD
Felbamate—Pancreatitis—Metformin—polycystic ovary syndrome	0.00527	0.0266	CcSEcCtD
Felbamate—GRIN2A—endocrine gland—polycystic ovary syndrome	0.00524	0.0832	CbGeAlD
Felbamate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.005	0.0252	CcSEcCtD
Felbamate—Bradycardia—Metformin—polycystic ovary syndrome	0.00438	0.0221	CcSEcCtD
Felbamate—Rhinitis—Metformin—polycystic ovary syndrome	0.00432	0.0218	CcSEcCtD
Felbamate—Hepatitis—Metformin—polycystic ovary syndrome	0.00431	0.0217	CcSEcCtD
Felbamate—CYP2E1—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00405	0.00562	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00402	0.00558	CbGpPWpGaD
Felbamate—Flushing—Metformin—polycystic ovary syndrome	0.004	0.0202	CcSEcCtD
Felbamate—CYP2E1—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.0039	0.00541	CbGpPWpGaD
Felbamate—Chills—Metformin—polycystic ovary syndrome	0.00386	0.0195	CcSEcCtD
Felbamate—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00373	0.00518	CbGpPWpGaD
Felbamate—Flatulence—Metformin—polycystic ovary syndrome	0.00369	0.0186	CcSEcCtD
Felbamate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00367	0.0185	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00366	0.00508	CbGpPWpGaD
Felbamate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00356	0.00494	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CDH15—polycystic ovary syndrome	0.00352	0.00489	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00351	0.00488	CbGpPWpGaD
Felbamate—Tremor—Metformin—polycystic ovary syndrome	0.00351	0.0177	CcSEcCtD
Felbamate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00348	0.0175	CcSEcCtD
Felbamate—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00344	0.00478	CbGpPWpGaD
Felbamate—Malaise—Metformin—polycystic ovary syndrome	0.00338	0.0171	CcSEcCtD
Felbamate—Palpitations—Metformin—polycystic ovary syndrome	0.00331	0.0167	CcSEcCtD
Felbamate—Hypertension—Metformin—polycystic ovary syndrome	0.00324	0.0163	CcSEcCtD
Felbamate—Myalgia—Metformin—polycystic ovary syndrome	0.00319	0.0161	CcSEcCtD
Felbamate—Chest pain—Metformin—polycystic ovary syndrome	0.00319	0.0161	CcSEcCtD
Felbamate—Discomfort—Metformin—polycystic ovary syndrome	0.00315	0.0159	CcSEcCtD
Felbamate—CYP2C19—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00312	0.00434	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00311	0.00432	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00311	0.00431	CbGpPWpGaD
Felbamate—Oedema—Metformin—polycystic ovary syndrome	0.00306	0.0154	CcSEcCtD
Felbamate—Infection—Metformin—polycystic ovary syndrome	0.00304	0.0153	CcSEcCtD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00301	0.00417	CbGpPWpGaD
Felbamate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.003	0.0151	CcSEcCtD
Felbamate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00296	0.0149	CcSEcCtD
Felbamate—Anorexia—Metformin—polycystic ovary syndrome	0.00292	0.0147	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00287	0.00398	CbGpPWpGaD
Felbamate—Hypotension—Metformin—polycystic ovary syndrome	0.00286	0.0144	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00284	0.00394	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0028	0.00389	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00279	0.0141	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00275	0.00382	CbGpPWpGaD
Felbamate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00275	0.0139	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00274	0.00381	CbGpPWpGaD
Felbamate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00273	0.0138	CcSEcCtD
Felbamate—Somnolence—Metformin—polycystic ovary syndrome	0.00272	0.0137	CcSEcCtD
Felbamate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00269	0.0136	CcSEcCtD
Felbamate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00266	0.0134	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00266	0.00369	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00264	0.00367	CbGpPWpGaD
Felbamate—Fatigue—Metformin—polycystic ovary syndrome	0.00264	0.0133	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00264	0.00366	CbGpPWpGaD
Felbamate—Constipation—Metformin—polycystic ovary syndrome	0.00262	0.0132	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0026	0.00361	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00258	0.00358	CbGpPWpGaD
Felbamate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00252	0.0127	CcSEcCtD
Felbamate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0025	0.0126	CcSEcCtD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00246	0.00341	CbGpPWpGaD
Felbamate—Urticaria—Metformin—polycystic ovary syndrome	0.00243	0.0123	CcSEcCtD
Felbamate—Abdominal pain—Metformin—polycystic ovary syndrome	0.00242	0.0122	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00239	0.00332	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00238	0.00331	CbGpPWpGaD
Felbamate—CYP2C19—vagina—polycystic ovary syndrome	0.00235	0.0373	CbGeAlD
Felbamate—GRIN2B—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00234	0.00324	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00232	0.00322	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0023	0.00319	CbGpPWpGaD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00225	0.00312	CbGpPWpGaD
Felbamate—Asthenia—Metformin—polycystic ovary syndrome	0.00219	0.0111	CcSEcCtD
Felbamate—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00219	0.0349	CbGeAlD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00219	0.00304	CbGpPWpGaD
Felbamate—Pruritus—Metformin—polycystic ovary syndrome	0.00216	0.0109	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00216	0.003	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00214	0.00297	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—DLG4—polycystic ovary syndrome	0.00211	0.00292	CbGpPWpGaD
Felbamate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00209	0.0106	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00209	0.0029	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00208	0.00289	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00206	0.00286	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00205	0.00285	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00204	0.00284	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00203	0.00282	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00202	0.00281	CbGpPWpGaD
Felbamate—Dizziness—Metformin—polycystic ovary syndrome	0.00202	0.0102	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00201	0.00279	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.002	0.00278	CbGpPWpGaD
Felbamate—Vomiting—Metformin—polycystic ovary syndrome	0.00195	0.00981	CcSEcCtD
Felbamate—Rash—Metformin—polycystic ovary syndrome	0.00193	0.00973	CcSEcCtD
Felbamate—Dermatitis—Metformin—polycystic ovary syndrome	0.00193	0.00972	CcSEcCtD
Felbamate—Headache—Metformin—polycystic ovary syndrome	0.00192	0.00967	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.00191	0.00266	CbGpPWpGaD
Felbamate—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00188	0.00261	CbGpPWpGaD
Felbamate—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00186	0.0295	CbGeAlD
Felbamate—Nausea—Metformin—polycystic ovary syndrome	0.00182	0.00917	CcSEcCtD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00181	0.00251	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—DLG4—polycystic ovary syndrome	0.00179	0.00249	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00177	0.00246	CbGpPWpGaD
Felbamate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00174	0.00241	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00169	0.00235	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00168	0.00234	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.00167	0.00232	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00166	0.0023	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00165	0.00229	CbGpPWpGaD
Felbamate—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00161	0.0256	CbGeAlD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00161	0.00224	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00159	0.00221	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—DLG4—polycystic ovary syndrome	0.00159	0.00221	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.0015	0.00208	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00148	0.00205	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—polycystic ovary syndrome	0.00142	0.00197	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00138	0.00191	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00136	0.00189	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00136	0.00189	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00132	0.00183	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00131	0.00181	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0013	0.0018	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0013	0.0018	CbGpPWpGaD
Felbamate—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0013	0.0206	CbGeAlD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00128	0.00178	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00125	0.00174	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00123	0.00171	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00122	0.0017	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00122	0.0017	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00121	0.00168	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.0012	0.00167	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.0012	0.00166	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00114	0.00158	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00114	0.00158	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00114	0.00158	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—DLG4—polycystic ovary syndrome	0.00113	0.00157	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00112	0.00156	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00112	0.00155	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00107	0.00148	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00106	0.00148	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00106	0.00147	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00105	0.00146	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00105	0.00146	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00102	0.00141	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00101	0.0014	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000992	0.00138	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000968	0.00134	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000967	0.00134	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000965	0.00134	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000955	0.00133	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000942	0.00131	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000929	0.00129	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000929	0.00129	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000899	0.00125	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000886	0.00123	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000878	0.00122	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000876	0.00122	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000864	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000849	0.00118	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000798	0.00111	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000798	0.00111	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000785	0.00109	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000784	0.00109	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00078	0.00108	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00077	0.00107	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000724	0.00101	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000714	0.000992	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—LEP—polycystic ovary syndrome	0.000699	0.00097	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000693	0.000963	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000686	0.000952	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000684	0.000949	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000669	0.000928	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00064	0.000888	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000637	0.000885	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000634	0.00088	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000633	0.000878	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000631	0.000876	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARG—polycystic ovary syndrome	0.000609	0.000845	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000605	0.00084	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—INS—polycystic ovary syndrome	0.000597	0.000829	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000583	0.000809	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000583	0.000809	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000582	0.000808	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT2—polycystic ovary syndrome	0.000577	0.000801	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000567	0.000787	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000559	0.000776	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000559	0.000776	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000551	0.000765	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000542	0.000752	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.00054	0.00075	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—polycystic ovary syndrome	0.000528	0.000734	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000528	0.000733	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000527	0.000731	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00052	0.000721	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000514	0.000714	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000492	0.000682	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000472	0.000655	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000469	0.000651	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000461	0.00064	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000461	0.00064	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000458	0.000636	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.00045	0.000624	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.00045	0.000624	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000444	0.000616	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000418	0.00058	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000417	0.000579	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000417	0.000578	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000411	0.000571	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000408	0.000567	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000386	0.000536	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000381	0.000529	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000377	0.000524	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000366	0.000508	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—polycystic ovary syndrome	0.000365	0.000507	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000362	0.000502	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000355	0.000493	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000355	0.000493	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000349	0.000485	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000342	0.000474	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000336	0.000467	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000336	0.000467	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000331	0.00046	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000311	0.000432	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000298	0.000413	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000297	0.000412	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000296	0.00041	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000282	0.000392	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000271	0.000376	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00027	0.000375	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00027	0.000375	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000269	0.000374	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000266	0.00037	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000265	0.000367	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—polycystic ovary syndrome	0.000261	0.000362	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000256	0.000356	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000251	0.000349	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000251	0.000348	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.00024	0.000333	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000236	0.000327	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000229	0.000318	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000228	0.000317	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000226	0.000314	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.00022	0.000306	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000215	0.000298	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000214	0.000297	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000214	0.000297	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000211	0.000294	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000209	0.00029	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000209	0.00029	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000204	0.000283	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000198	0.000274	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000197	0.000274	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000194	0.00027	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000182	0.000253	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000179	0.000249	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000176	0.000245	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.00017	0.000236	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00017	0.000236	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000168	0.000233	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000163	0.000227	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000163	0.000227	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000162	0.000225	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000162	0.000225	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000161	0.000224	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00016	0.000222	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000154	0.000213	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000152	0.000211	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.00015	0.000208	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000144	0.0002	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000138	0.000191	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000137	0.00019	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.000131	0.000181	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TH—polycystic ovary syndrome	0.00013	0.00018	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	0.000126	0.000175	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000126	0.000174	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000124	0.000172	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000123	0.00017	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000119	0.000165	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	0.000119	0.000165	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000115	0.00016	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000109	0.000152	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000106	0.000147	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	0.000106	0.000147	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000102	0.000142	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	0.000101	0.00014	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.81e-05	0.000136	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	9.69e-05	0.000135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	9.56e-05	0.000133	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	9.36e-05	0.00013	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	9.23e-05	0.000128	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—INS—polycystic ovary syndrome	9.18e-05	0.000128	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.15e-05	0.000127	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.01e-05	0.000125	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	8.91e-05	0.000124	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.79e-05	0.000108	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.58e-05	0.000105	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	7.22e-05	0.0001	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.13e-05	9.9e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	7.12e-05	9.89e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—INS—polycystic ovary syndrome	7.09e-05	9.84e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.36e-05	8.84e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.06e-05	8.42e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.75e-05	7.98e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.36e-05	7.44e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.34e-05	6.03e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.28e-05	5.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.26e-05	5.92e-05	CbGpPWpGaD
